Geode Capital Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.1M | Buy |
660,928
+42,794
| +7% | +$312K | ﹤0.01% | 2725 |
|
|
2025
Q4 | $3.79M | Buy |
618,134
+6,311
| +1% | +$68.2K | ﹤0.01% | 2914 |
|
|
2025
Q3 | $11.3M | Buy |
611,823
+5,532
| +0.9% | +$88.9K | ﹤0.01% | 2353 |
|
|
2025
Q2 | $7.89M | Buy |
606,291
+36,671
| +6% | +$434K | ﹤0.01% | 2498 |
|
|
2025
Q1 | $6.03M | Buy |
569,620
+14,636
| +3% | +$232K | ﹤0.01% | 2570 |
|
|
2024
Q4 | $9.42M | Buy |
554,984
+3,186
| +0.6% | +$60K | ﹤0.01% | 2416 |
|
|
2024
Q3 | $12.8M | Buy |
551,798
+5,789
| +1% | +$124K | ﹤0.01% | 2229 |
|
|
2024
Q2 | $13.3M | Sell |
546,009
-4,254
| -0.8% | -$129K | ﹤0.01% | 2154 |
|
|
2024
Q1 | $18.6M | Buy |
550,263
+11,998
| +2% | +$425K | ﹤0.01% | 1965 |
|
|
2023
Q4 | $17M | Buy |
538,265
+26,097
| +5% | +$620K | ﹤0.01% | 2013 |
|
|
2023
Q3 | $13.1M | Buy |
512,168
+16,992
| +3% | +$523K | ﹤0.01% | 2093 |
|
|
2023
Q2 | $14.2M | Buy |
495,176
+27,060
| +6% | +$737K | ﹤0.01% | 2078 |
|
|
2023
Q1 | $11.2M | Buy |
468,116
+18,177
| +4% | +$326K | ﹤0.01% | 2191 |
|
|
2022
Q4 | $7.63M | Buy |
449,939
+33,148
| +8% | +$578K | ﹤0.01% | 2436 |
|
|
2022
Q3 | $6.18M | Buy |
416,791
+24,254
| +6% | +$407K | ﹤0.01% | 2556 |
|
|
2022
Q2 | $6.18M | Buy |
392,537
+21,554
| +6% | +$423K | ﹤0.01% | 2579 |
|
|
2022
Q1 | $10M | Sell |
370,983
-4,130
| -1% | -$105K | ﹤0.01% | 2343 |
|
|
2021
Q4 | $13.9M | Sell |
375,113
-25,256
| -6% | -$1.03M | ﹤0.01% | 2217 |
|
|
2021
Q3 | $19.1M | Buy |
400,369
+16,752
| +4% | +$751K | ﹤0.01% | 1986 |
|
|
2021
Q2 | $13M | Buy |
383,617
+27,721
| +8% | +$938K | ﹤0.01% | 2281 |
|
|
2021
Q1 | $14.7M | Buy |
355,896
+31,500
| +10% | +$1.88M | ﹤0.01% | 2081 |
|
|
2020
Q4 | $14.1M | Buy |
324,396
+54,862
| +20% | +$3.72M | ﹤0.01% | 1930 |
|
|
2020
Q3 | $11.6M | Buy |
269,534
+57,333
| +27% | +$2.85M | ﹤0.01% | 1857 |
|
|
2020
Q2 | $9.92M | Buy |
212,201
+123,714
| +140% | +$4.26M | ﹤0.01% | 1924 |
|
|
2020
Q1 | $1.2M | Buy |
88,487
+3,992
| +5% | +$51.1K | ﹤0.01% | 2933 |
|
|
2019
Q4 | $918K | Buy |
84,495
+5,745
| +7% | +$60.1K | ﹤0.01% | 3307 |
|
|
2019
Q3 | $808K | Buy |
78,750
+65,277
| +485% | +$706K | ﹤0.01% | 3306 |
|
|
2019
Q2 | $127K | Buy |
+13,473
| New | +$98.9K | ﹤0.01% | 3902 |
|
|
2017
Q4 | – | Sell |
-1,576
| Closed | -$11K | – | 4025 |
|
|
2017
Q3 | $11K | Hold |
1,576
| – | – | ﹤0.01% | 4036 |
|
|
2017
Q2 | $12K | Sell |
1,576
-673
| -30% | -$5.42K | ﹤0.01% | 4069 |
|
|
2017
Q1 | $17K | Buy |
2,249
+92
| +4% | +$852 | ﹤0.01% | 4048 |
|
|
2016
Q4 | $31K | Buy |
2,157
+61
| +3% | +$912 | ﹤0.01% | 3971 |
|
|
2016
Q3 | $36K | Buy |
2,096
+15
| +0.7% | +$485 | ﹤0.01% | 3947 |
|
|
2016
Q2 | $65K | Hold |
2,081
| – | – | ﹤0.01% | 3883 |
|
|
2016
Q1 | $55 | Buy |
+2,081
| New | +$70.5K | ﹤0.01% | 3954 |
|
Other funds holding ARCT
AIM
NAMA
VCM
VPM
